Advertisement

Gastrointestinal Complications

  • Eneida Nemecek
Chapter

Abstract

Gastrointestinal and hepatic complications are common in the hematopoietic stem cell transplant (HSCT) patient. The agents used in the conditioning regimen induce direct disruption of the intestinal barrier as well as indirect damage from cytokine release and generalized inflammatory state. These events lead to permeation of bacteria and endotoxins through the bowel wall, with subsequent organ damage and increased risk for infections. Similarly, HSCT conditioning can directly affect the hepatic parenchyma or hepatic sinusoids. The immunosuppressed state of the HSCT patient also increases the risk for opportunistic infections of the gastrointestinal tract and liver.

Keywords

Hematopoietic Stem Cell Transplant Conditioning Regimen Fulminant Hepatic Failure Gall Bladder Disease Gemtuzumab Ozogamicin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Barker, C., Anderson, R., Sauve, R., Butzner, J. (2005). GI complications in pediatric patients post-BMT. Bone Marrow Transplant, 36(1):51–58.CrossRefPubMedGoogle Scholar
  2. Bresters, D., Van Gils, I., Dekker, F., Lankester, A., Bredius, R., Schweizer, J. (2008). Abnormal liver enzymes 2 years after haematopoietic stem cell transplantation in children: Prevalence and risk factors. Bone Marrow Transplant, 41(1):27–31.CrossRefPubMedGoogle Scholar
  3. Cox, G., Matsui, S., Lo, R., Hinds, M., Bowden, R., Hackman, R., et al. (1994). Etiology and outcome of diarrhea after marrow transplantation; a prospective study. Gastroenterology, 107(5):1398–1407.PubMedGoogle Scholar
  4. Crouch, M., Restino, M., Cruz, J., Perry, J., Hurd, D. (1996). Octreotide acetate in refractory bone marrow transplant-associated diarrhea. Ann Pharmacothera, 30(4):331–336.Google Scholar
  5. Firpi, R., Nelson, D. (2006). Viral hepatitis: Manifestations and management strategy. Hematology Am Soc Hematol Educ Program, 375–380.Google Scholar
  6. Geller, R., Gilmore, C., Dix, S., Lin, L., Topping, D., Davidson, T., et al. (1995). Randomized trial of loperimide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients. Am J Hematol, 50(3):167–172.CrossRefPubMedGoogle Scholar
  7. Ho, V., Revta, C., Richardson, P. (2008). Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Update on defibrotide and other current investigational therapies. Bone Marrow Transplant, 41(3):229–237.CrossRefGoogle Scholar
  8. Ippoliti, C., Champlin, R., Bugazia, N., Przepiorka, D., Neumann, J., Giralt, S., et al. (1997). Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies. J Clin Oncol, 5(11):3350–3354.Google Scholar
  9. Johansson, J., Abrahamsson, H., Ekman, T. (2003). Gastric emptying after autologous hematopoietic stem cell transplantation: A prospective trial. Bone Marrow Transplant, 32(8):815–819.CrossRefPubMedGoogle Scholar
  10. Ko, C., Gooley, T., Schoch, H., Myerson, D., Hackman, R., Shulman, H., et al. (1997). Acute pancreatitis in marrow transplant patients: Prevalence at autopsy and risk factor analysis. Bone Marrow Transplant, 20(12):1081–1086.CrossRefPubMedGoogle Scholar
  11. Malone, F., Leisenring, W., Storer, B. L., Stern, J., Bouvier, M., Martin, P., et al. (2007). Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant. Bone Marrow Transplant, 40(8):765–772.CrossRefPubMedGoogle Scholar
  12. Murray, S., Pindoria, S. (2009, January 21). Nurtrition support for bone marrow transplant patients. Retrieved from mrw.interscience.wiley.com: CD002920.Google Scholar
  13. Sakai, M., Strasser, S., Shulman, H., McDonald, S., Schoch, H., McDonald, G. (2009). Severe hepatocellular injury after hematopoietic stem cell transplant: Incidence, etiology and outcome. Bone Marrow Transplant, 44(7):441–447.CrossRefPubMedGoogle Scholar
  14. Schulenburg, A., Turetschedk, K., Wrba, F., Vogelsang, H., Greinix, H., Keil, F., et al. (2004). Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Ann Hematol, 83(2):101–106.CrossRefPubMedGoogle Scholar
  15. Schwartz, J., Wolford, J., Thornquist, M., Hockenbery, D., Murakami, C., Drennan, F., et al. (2001). Severe gastrointestinal bleeding after hematopoietic stem cell transplantation, 1987–1997: Incidence, causes, and outcome. Am J Gastroenterol, 96(2):385–393.PubMedGoogle Scholar
  16. Teefey, S., Hollister, M., Lee, S., Jacobson, A., Higano, C., Bianco, J., et al. (1994). Gallbladder sludge formation after bone marrow transplant: Sonographic observations. Abdom Imaging, 19(1):57–60.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Eneida Nemecek
    • 1
  1. 1.Pediatric Blood and Marrow Transplantation, Doernbecher Children’s HospitalPortlandUSA

Personalised recommendations